Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, an integrated, real-time cloud native platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately one million physicians; 574,000 clinical facilities; and approximately 332 million individuals and 61 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
IPO Year: 2015
Exchange: NASDAQ
Website: inovalon.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/25/2021 | Overweight → Sector Weight | Keybanc | |
| 8/20/2021 | Buy → Neutral | BTIG | |
| 7/29/2021 | $35.00 → $40.00 | Overweight | Keybanc |
| 7/28/2021 | $35.00 → $45.00 | Outperform | SVB Leerink |
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Keybanc downgraded Inovalon Holdings from Overweight to Sector Weight
BTIG downgraded Inovalon Holdings from Buy to Neutral
Keybanc reiterated coverage of Inovalon Holdings with a rating of Overweight and set a new price target of $40.00 from $35.00 previously
SVB Leerink reiterated coverage of Inovalon Holdings with a rating of Outperform and set a new price target of $45.00 from $35.00 previously
Robert W. Baird initiated coverage of Inovalon with a rating of Outperform and set a new price target of $41.00
Baird initiated coverage of Inovalon Holdings with a rating of Outperform and set a new price target of $27.00
SVB Leerink reiterated coverage of Inovalon Holdings with a rating of Outperform and set a new price target of $35.00 from $31.00 previously
Keybanc reiterated coverage of Inovalon Holdings with a rating of Overweight and set a new price target of $35.00 from $29.00 previously
Morgan Stanley reiterated coverage of Inovalon Holdings with a rating of Equal-Weight and set a new price target of $25.00 from $23.00 previously
SVB Leerink reiterated coverage of Inovalon Holdings with a rating of Outperform and set a new price target of $31.00 from $27.00 previously
15-12B - Inovalon Holdings, Inc. (0001619954) (Filer)
S-8 POS - Inovalon Holdings, Inc. (0001619954) (Filer)
S-8 POS - Inovalon Holdings, Inc. (0001619954) (Filer)
SC 13E3/A - Inovalon Holdings, Inc. (0001619954) (Subject)
8-K - Inovalon Holdings, Inc. (0001619954) (Filer)
25-NSE - Inovalon Holdings, Inc. (0001619954) (Subject)
SC 13E3/A - Inovalon Holdings, Inc. (0001619954) (Subject)
8-K - Inovalon Holdings, Inc. (0001619954) (Filer)
10-Q - Inovalon Holdings, Inc. (0001619954) (Filer)
SC 13E3/A - Inovalon Holdings, Inc. (0001619954) (Subject)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
Fastest customizable press release news feed in the world
BOWIE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the completion of its acquisition by an equity consortium led by Nordic Capital, and joined by Insight Partners, as lead co-investor, 22C Capital, and Inovalon founder and chief executive officer Keith Dunleavy, M.D. and certain Class B stockholders of Inovalon. The acquisition was previously announced on August 19, 2021, and was approved by Inovalon's stockholders on November 16, 2021. In accordance with the terms of the agreement, Inovalon stockholders will receive $41.00 in cash for each share of Class A Common Stock and Cla
BOWIE, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual ScriptMed® Conference will take place virtually from November 8-9, 2021. This prestigious two-day event features the industry's leading executives and thought leaders discussing the ways in which technology can enable collaborative partnerships to facilitate data sharing and empower patients and their providers. A panel of prominent specialty pharmacy experts from AllianceRx Walgreens Prime, AIDS Healthcare Foundation, and Perigon Pharmacy will open the ScriptMed® Conference, sharing their thoughts and futuristic vie
Former CMS Administrator Seema Verma, Snowflake CEO Frank Slootman, and Aetna/CVS Chief Medical Officer Dr. Kyu Rhee to Deliver Keynotes on Data-Driven Healthcare BOWIE, Md., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual Client Congress will take place virtually from October 18-19, 2021. Client Congress builds on a decade of bringing together the nation's most influential voices to address the programs, perspectives, and policies shaping U.S. healthcare and to share insights intended to help organizations thrive in today's dynamic marketplace. This is the second time in thi
WALTHAM, Mass., Sept. 21, 2021 /PRNewswire/ -- CorEvitas, LLC, the gold-standard leader in longitudinal real-world data in autoimmune and inflammatory diseases, today announced that it has expanded its engagement with Inovalon's (NASDAQ:INOV) life sciences business unit specializing in data-driven healthcare analytics and strategic advisory services, to provide a holistic view of patients with rheumatoid arthritis or psoriasis. In conjunction with CorEvitas' granular clinical data on validated physician assessments and patient-reported outcomes, this collaboration focuses on r
BOWIE, Md., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it has entered into a definitive agreement to be acquired by an equity consortium led by Nordic Capital, and joined by Insight Partners, as lead co-investor, 22C Capital, and Inovalon founder and Chief Executive Officer Keith Dunleavy, M.D. and certain Class B stockholders of Inovalon in an all-cash transaction with an enterprise value of approximately $7.3 billion. Under the terms of the agreement, Inovalon stockholders will receive $41.00 per share in cash for each share of Class A Common Stock or Class B Common Stock,
BOWIE, Md., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon, and Jonathan R. Boldt, chief financial officer of Inovalon, will present at the KeyBanc Technology Leadership Forum, which will be held virtually. The virtual presentation will take place in a fireside chat format today at 12:00 noon ET. Investors may access a live webcast on the Investor Relations section of Inovalon's website at https://investors.inovalon.com. An archived version will remain posted for a limited time. In addition, man
Second Quarter 2021 Highlights Q2 revenue of $190.4 million, up 17% YoY and 8% sequentiallyQ2 subscription-based platform revenue of $168.7 million, up 19% YoY and 7% sequentially, equating to 89% of Q2 total revenueQ2 net income of $9.6 million, resulting in diluted net income of $0.06 per shareQ2 Non-GAAP net income of $27.9 million, resulting in Non-GAAP net income of $0.19 per share, up 27% YoYQ2 Adjusted EBITDA of $64.1 million, up 13% YoY and 9% sequentially, resulting in adjusted EBITDA margin of 33.7%Q2 new sales Annual Contract Value (ACV)1 totaled $60.5 million and platform new sales ACV totaled $43.2 million Debt & Cash Highlights Cash balance as of June 30, 2021 totaling $117.
BOWIE, Md., July 14, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will hold a conference call for investors on Wednesday, July 28, 2021, at 5:00 p.m. Eastern Time. During the conference call, management will review highlights from the Company's second quarter 2021 financial results, which will be announced via press release after the close of market trading. The conference call can be accessed by dialing (855) 783-2604, conference ID 4583925; international callers should dial (631) 485-4882 using the same ID. The call will be available for replay on Inovalon's website at www.inovalon
BOWIE, Md., June 28, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the appointment of Eron S. Kelly as its Corporate President. Mr. Kelly brings more than 20 years of experience in global software and cloud-based technology growth as a seasoned executive leader at Amazon and Microsoft. As Inovalon's Corporate President, Mr. Kelly will be responsible for the management, operation, and results of the Company's multiple business units, their respective growth, product offerings, value achievement, and performance, as well as related support of customer and strategic relationships, total cust
BOWIE, Md., June 24, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced an expansion and extension of the long-term engagement with Walmart (NYSE:WMT) to provide cloud-based capabilities through the Inovalon ONE® Platform in its extensive network of pharmacies nationwide as part of its data-driven strategy to improve outcomes and economics for its customers. Under the agreement, Walmart will extend its engagement into 2028 and will look to expand its use of Inovalon's cloud-based capabilities through the Inovalon ONE® Platform by extending the use of ScriptMed® Cloud to empower the clinical care m
Live Leadership Updates
BOWIE, Md., June 28, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the appointment of Eron S. Kelly as its Corporate President. Mr. Kelly brings more than 20 years of experience in global software and cloud-based technology growth as a seasoned executive leader at Amazon and Microsoft. As Inovalon's Corporate President, Mr. Kelly will be responsible for the management, operation, and results of the Company's multiple business units, their respective growth, product offerings, value achievement, and performance, as well as related support of customer and strategic relationships, total cust
Live finance-specific insights
Second Quarter 2021 Highlights Q2 revenue of $190.4 million, up 17% YoY and 8% sequentiallyQ2 subscription-based platform revenue of $168.7 million, up 19% YoY and 7% sequentially, equating to 89% of Q2 total revenueQ2 net income of $9.6 million, resulting in diluted net income of $0.06 per shareQ2 Non-GAAP net income of $27.9 million, resulting in Non-GAAP net income of $0.19 per share, up 27% YoYQ2 Adjusted EBITDA of $64.1 million, up 13% YoY and 9% sequentially, resulting in adjusted EBITDA margin of 33.7%Q2 new sales Annual Contract Value (ACV)1 totaled $60.5 million and platform new sales ACV totaled $43.2 million Debt & Cash Highlights Cash balance as of June 30, 2021 totaling $117.
This live feed shows all institutional transactions in real time.
SC 13G/A - Inovalon Holdings, Inc. (0001619954) (Subject)
SC 13G/A - Inovalon Holdings, Inc. (0001619954) (Subject)
SC 13G/A - Inovalon Holdings, Inc. (0001619954) (Subject)
SC 13G/A - Inovalon Holdings, Inc. (0001619954) (Subject)